BOSTON, MA -- (Marketwire) -- 05/27/10 -- Elsevier Business Intelligence, the medtech industry's leading provider of strategic partnership and investment conferences, will host 'IN3 East' on June 9-11 in Boston at The Westin Copley Place. This major event is the prelude to Elsevier's 'Medical Device Investor Day' investment conference, also being held.

The kick-off event will be a panel discussion -- 'What Are Buyers Looking for in 2010?' -- that will feature Dennis Crowley, Vice President of Corporate Development, Covidien; and Tom Robinson, Vice President of Business Development, Boston Scientific. Panel topics will include: -- What is your current philosophy/approach to investments? -- What role does M&A play? -- What do you believe is the success rate of device M&A deals? -- What technology/therapeutic areas are currently of particular interest? -- In looking for M&A opportunities, how often do you look for technologies outside of your primary clinical spaces? -- Small companies are always interested in learning the best ways to get in touch with potential acquirers. What is the best way for a start-up to reach out to you? Do you like companies to contact you directly or do you prefer to make the contacts yourself? -- At what stage of product development do you like to make contacts with companies? -- Can you offer small companies some do's and don'ts of dealmaking negotiations? -- At what point in the discussion is it appropriate to begin to talk to companies about valuation and do you provide guidelines in terms of how you value companies? -- How much does competitive pressure contribute to driving up deal prices, and does that increase when other large potential acquirers are involved in the bidding? -- Are there enough venture-backed small companies in the pipeline so that you're satisfied that you're seeing a robust flow of opportunities?

IN3 East is the largest annual strategic partnership and investment meeting for senior-level medical technology executives. Several hundred venture capital firms and medical technology companies are expected to be represented at IN3 East to hear about the latest innovations and investment opportunities from more than 50 emerging medical technology companies seeking funding and/or strategic partnerships.

Whether you are (a) an innovator looking for the opportunity to build visibility for your technology, or (b) a large device company or health care investment firm in search of high-quality opportunities, or (c) a service provider seeking to support innovators with their needs, IN3 conferences are known as the premier medtech partnering events in the industry. Despite an improving funding environment, medtech start-ups continue to encounter stiff competition for a limited volume of capital resources. To ensure success, industry leaders advise innovators to raise capital early, plan for longer fundraising efforts, and seek out all opportunities.

For more information about IN3 East and Medical Device Investor Day, please contact: Kristy Kennedy at 1-480-985-9512 or Kayleen Kell at 1-888-290-2225 (USA only), or email IN3@Elsevier.com.

Additional IN3 events in 2010 -- Oct. 27-29, IN3 Summit, San Francisco, Grand Hyatt. Feb. 22-24, 2011, IN3 West 2011, Las Vegas, The Venetian Resort. For more information, please contact: Kristy Kennedy at 1-480-985-9512 or Kayleen Kell at 1-888-290-2225 (USA only), or email IN3@Elsevier.com.

About Elsevier Business Intelligence
Elsevier Business Intelligence, an Elsevier company, is a global information supplier providing business intelligence on regulatory, business and reimbursement issues that are vital to the healthcare industry. Through a range of products including publications, conferences, databases and reports, Elsevier Business Intelligence places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge, by providing the perfect combination of news and information together with penetrating insight and analysis. Elsevier Business Intelligence (http://www.elsevierbi.com) has offices in the U.S. in Bridgewater, N.J.; Norwalk, Conn.; Rockville, Md.; and Irvine, Calif.

About Elsevier
Elsevier is a world-leading publisher of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet (www.thelancet.com) and Cell (www.cell.com), and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include ScienceDirect (www.sciencedirect.com), Scopus (www.scopus.com), Reaxys (www.reaxys.com), MD Consult (www.mdconsult.com) and Nursing Consult (www.nursingconsult.com), which enhance the productivity of science and health professionals, and the SciVal suite (www.scival.com) and MEDai's Pinpoint Review (www.medai.com), which help research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier (www.elsevier.com) employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC (www.reedelsevier.com), a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).